No Detail Found!

Clinical and biochemical indicators of disease severity and neurological findings in COVID-19: A study of King Edward Medical University (KEMU), Pakistan

Author(s)
Sadaf Iftikhar Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Mamoona Ghias Department of Medicine, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Saman Shahid Department of Sciences & Humanities, National University of Computer and Emerging Sciences (NUCES), FAST Lahore Campus,Lahore,Pakistan
Muhammad Rashid Ali Department of Medicine, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Muhammad Umar Hassan Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Ahsan Numan Department of Neurology, King Edward Medical University (KEMU), Mayo Hospital,Lahore,Pakistan
Abstract
This study investigated the significance of difference between presence and absence of different neurological findings in COVID-19, in relation with the biochemistry. Various significant correlations in connection with the disease severity and clinical factors were also identified. 351 COVID-19 patients were included. Different laboratory/ clinical findings were investigated. Correlations Kendall's tau and Pearson Chi-Square were applied to find the correlations between severity and clinical findings. The Mann-Whitney Test was applied for a comparison between two types of neurological groups for each biochemistry parameter. Headache was reported in 28% and dizziness in 13% patients. The impaired smell and impaired taste were reported in 28.5% and 36.2% patients, respectively. The muscle pain was present in 39% patients. 80% patients had low lymphocytes & 70% had high neutrophils. 54.5% were found with high ALP. LDH was elevated in 73%. Severity was found significantly correlated with decreased oxygen saturation, age and raised levels of urea, creatinine and LDH. The groups (with/without CNS involvement) were statistically different in ALP, groups (with/without PNS involvement) in WBC, lymphocytes, neutrophils, ALP, urea, creatinine, CK, CKMB and LDH and groups (with/without MSK involvement) in WBC. Oxygen saturation, age, urea, creatinine and LDH are significant indicators of disease severity in COVID-19. The altered levels of different biochemistry can impact the neurological states of COVID-19 patients.
Publication Details
Page(s) 275-281
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
central nervous system, Disease severity, Lymphocytes, ALP, Covid-19, COVID-19, LDH, Oxygen saturation
References
Baig AM,Khaleeq A,Ali U,Syeda H U .2020 .Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction and proposed neurotropic mechanisms. ACS Chem, 11(7) : 995-998.
Bilinska K and Butowt R .2020 .Anosmia in COVID-19: A bumpy road to establishing a cellular mechanism. ACS Chem, 11(15) : 2152-2155.
Cipollaro L,Giordano L,Padulo J,Oliva F,Maffulli N. F .2020 .Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. , : .
Desforges M,Le Coupanec A,Dubeau P,Bourgouin A,Lajoie L,Dube M,Talbot PJ M .2020 .Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system?. Viruses, 12(1) : 14.
Guan WJ,Ni ZY,Hu Y,Liang WH,Ou CQ,He JX,Liu L,Shan H,Lei CL,Hui DS,Du B .2020 .Clinical characteristics of coronavirus disease 2019 in China. J. Med, 382(18) : 1708-1720.
Helms J,Kremer S,Merdji H,Clere-Jehl R,Schenck M,Kummerlen C,Collange O,Boulay C,Fafi-Kremer S,Ohana M,Anheim M M .2020 .Neurologic features in severe SARS-CoV-2 infection. J. Med, : .
Henry BM .2020 .COVID-19, ECMO and lymphopenia: A word of caution. Lancet Respir. Med, 8(4) : e24.
Kellett KA,Williams J,Vardy ER,Smith AD,Hooper NM .2011 .Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function. Int. J. Mol. Epidemiol. Genetics, 2(2) : 114.
Kucuk A,Cure MC,Cure E .2020 .Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin. Rheumatol, 26(1) : .
Li Z,Liu T,Yang N,Han D,Mi X,Li Y,Liu K,Vuylsteke A,Xiang H,Guo X H .2020 .Neurological manifestations of patients with COVID-19: Potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Frontiers Med, 14(5) : 533-541.
Lian J,Jin X,Hao S,Jia H,Cai H,Zhang X,Hu J,Zheng L,Wang X,Zhang S,Ye C .2020 .Epidemiological, clinical and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China. Influenza Other Respir. Viruses, 14 : 564-574.
Mao L,Wang M,Chen S,He Q,Chang J,Hong C,Zhou Y,Wang D,Miao X,Hu Y,Li Y Y .2020 .Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: A retrospective case series study. , : .
Schutgens RE .2020 .D-dimer in COVID-19: A guide with Pitfalls. e4(22)., 4(4) : .
Silva SJRd,Silva C,Guarines K,Mendes R,Pardee KM,Kohl A,Pena L A .2020 .Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. , 4(9) : 2319-36.
Tang N,Li D,Wang X,Sun Z X .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemostasis., 18(4) : 844-847.
Velavan TP,Meyer CG .2020 .. The COVID-19 epidemic. Tropical Med, 25(3) : 278.
Xia H and Lazartigues E .2008 .Angiotensin-converting enzyme 2 in the brain: Properties and future directions. J. Neurochem., 107(6) : 1482-1494.
Yachou Y,El Idrissi A,Belapasov V,Benali SA .2020 .Neuroinvasion, neurotropic and neuro-inflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. , 41 : 2657-2669.
Zhao Y,Zhao Z,Wang Y,Zhou Y,Ma Y,Zuo W Y .2020 .Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. , : .
0

Citations

0

Downloads

11

Views